Lannett Reports the Completion of Patient Dosing in Pivotal Clinical Trial for Biosimilar Insulin Glargine
Shots: The company has completed the patient dosing in the PK and PD study of bios...
Teva’s Ranivisio (biosimilar, ranibizumab) Receives EC’s Marketing Authorization for Retinal Diseases
Shots: The EC has granted the marketing authorization for Ranivisio, a biosimilar...
Alvotech Reports the Initiation of Confirmatory (AVT03-GL-C01) Study for AVT03, a Proposed Biosimilar to Prolia and Xgeva to Treat...
Shots: The company initiated a confirmatory (AVT03-GL-C01) study to evaluate AVT03...
Lupin Entered into an Exclusive License Agreement with I’rom for Denosumab Biosimilar in Japan
Shots: Lupin will receive multiple milestones fees payments & I’rom will...
Celltrion Healthcare’s Vegzelma (biosimilar, bevacizumab) Receives the EC’s Approval for the Treatment of Cancers
Shots: The EC has approved Vegzelma, biosimilar bevacizumab referencing EU-approve...
Samsung Bioepis and Organon’s Hadlima (biosimilar, adalimumab) Receive the US FDA’s Approval for Chronic Autoimmune Diseases
Shots: The US FDA has approved Hadlima (biosimilar, adalimumab) for patients suffe...
